Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
- PMID: 33968793
- PMCID: PMC8102866
- DOI: 10.3389/fcimb.2021.601968
Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
Abstract
The emergence of carbapenem-resistant Enterobacterales (CRE) has become a major public health concern. Moreover, its colonization among residents of long-term care facilities (LTCFs) is associated with subsequent infections and mortality. To further explore the various aspects concerning CRE in LTCFs, we conducted a literature review on CRE colonization and/or infections in long-term care facilities. The prevalence and incidence of CRE acquisition among residents of LTCFs, especially in California, central Italy, Spain, Japan, and Taiwan, were determined. There was a significant predominance of CRE in LTCFs, especially in high-acuity LTCFs with mechanical ventilation, and thus may serve as outbreak centers. The prevalence rate of CRE in LTCFs was significantly higher than that in acute care settings and the community, which indicated that LTCFs are a vital reservoir for CRE. The detailed species and genomic analyses of CRE among LTCFs reported that Klebsiella pneumoniae is the primary species in the LTCFs in the United States, Spain, and Taiwan. KPC-2-containing K. pneumoniae strains with sequence type 258 is the most common sequence type of KPC-producing K. pneumoniae in the LTCFs in the United States. IMP-11- and IMP-6-producing CRE were commonly reported among LTCFs in Japan. OXA-48 was the predominant carbapenemase among LTCFs in Spain. Multiple risk factors associated with the increased risk for CRE acquisition in LTCFs were found, such as comorbidities, immunosuppressive status, dependent functional status, usage of gastrointestinal devices or indwelling catheters, mechanical ventilation, prior antibiotic exposures, and previous culture reports. A high CRE acquisition rate and prolonged CRE carriage duration after colonization were found among residents in LTCFs. Moreover, the patients from LTCFs who were colonized or infected with CRE had poor clinical outcomes, with a mortality rate of up to 75% in infected patients. Infection prevention and control measures to reduce CRE in LTCFs is important, and could possibly be controlled via active surveillance, contact precautions, cohort staffing, daily chlorhexidine bathing, healthcare-worker education, and hand-hygiene adherence.
Keywords: Enterobacteriaceae; carbapenemases; long-term care facilities; metallo-beta-lactamase; oxacillinase.
Copyright © 2021 Chen, Jean, Lee, Lu, Ko, Liu and Hsueh.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48.Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2127-2135. doi: 10.1007/s10096-017-3035-3. Epub 2017 Jun 21. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28639165
-
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.MMWR Morb Mortal Wkly Rep. 2009 Mar 20;58(10):256-60. MMWR Morb Mortal Wkly Rep. 2009. PMID: 19300408
-
Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.MMWR Morb Mortal Wkly Rep. 2015 Dec 4;64(47):1315-6. doi: 10.15585/mmwr.mm6447a3. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26633574
-
Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.Med Mal Infect. 2014 Feb;44(2):51-6. doi: 10.1016/j.medmal.2013.11.007. Epub 2013 Dec 18. Med Mal Infect. 2014. PMID: 24360201 Review.
-
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.Clin Infect Dis. 2011 Jul 1;53(1):60-7. doi: 10.1093/cid/cir202. Clin Infect Dis. 2011. PMID: 21653305 Review.
Cited by
-
Genomic characterization of a WHO critical priority isolate Enterobacter kobei ST2070 harboring OXA-10, KPC-2, and CTX-M-12 recovered from a water irrigation channel in Ecuador.Heliyon. 2024 Feb 16;10(5):e26379. doi: 10.1016/j.heliyon.2024.e26379. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38449644 Free PMC article.
-
Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma Medical Center, Ethiopia.Front Microbiol. 2024 Jan 24;15:1336387. doi: 10.3389/fmicb.2024.1336387. eCollection 2024. Front Microbiol. 2024. PMID: 38328425 Free PMC article.
-
Healthcare-Associated Infections and Prevention Programs in General Nursing versus Residential Homes-Results of the Point Prevalence Survey in Polish Long-Term Care Facilities.Medicina (Kaunas). 2024 Jan 11;60(1):137. doi: 10.3390/medicina60010137. Medicina (Kaunas). 2024. PMID: 38256397 Free PMC article.
-
Epidemiological Characteristics of Carbapenem-Resistant Enterobacterales in Japan: A Nationwide Analysis of Data from a Clinical Laboratory Center (2016-2022).Pathogens. 2023 Oct 16;12(10):1246. doi: 10.3390/pathogens12101246. Pathogens. 2023. PMID: 37887763 Free PMC article.
-
Asymptomatic gastrointestinal carriage of multidrug-resistant carbapenemase-producing Enterobacteriaceae among children under five years in a Kenyan hospital.IJID Reg. 2023 Sep 27;9:25-31. doi: 10.1016/j.ijregi.2023.07.007. eCollection 2023 Dec. IJID Reg. 2023. PMID: 37818227 Free PMC article.
References
-
- Ambretti S., Bassetti M., Clerici P., Petrosillo N., Tumietto F., Viale P., et al. . (2019). Screening for Carriage of Carbapenem-Resistant Enterobacteriaceae in Settings of High Endemicity: A Position Paper From an Italian Working Group on CRE Infections. Antimicrob. Resist. Infect. Control. 8, 136. 10.1186/s13756-019-0591-6 - DOI - PMC - PubMed
-
- Ben-David D., Masarwa S., Navon-Venezia S., Mishali H., Fridental I., Rubinovitch B., et al. . (2012). Risk Factors for Developing Clinical Infection With Carbapenem-Resistant Klebsiella pneumoniae in Hospital Patients Initially Only Colonized With Carbapenem-Resistant K. pneumoniae . Am. J. Infect. Control. 40, 421–425. 10.1016/j.ajic.2011.05.022 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
